Chimeric immunoligand containing interleukin-2 receptor binding sequence; human recombinant interleukin-2 and antibody constant region fusion protein construction using plasmid pIL-2IgG1 for e.g. leukemia and automimmune disease therapy and recombinant vaccine: Protein Design Labs USA 5349 053; 20 September 1994

• Book ID: 116117036
• Publisher: Elsevier Science
• Year: 1995
• Tongue: English
• Weight: 174 KB
• Volume: 13
• Category: Article
• ISSN: 0264-410X
• DOI: 10.1016/0264-410x(95)90173-m